Cargando…

Alternative splicing of LSD1+8a in neuroendocrine prostate cancer is mediated by SRRM4

Neuroendocrine prostate cancer (NEPC) is the most virulent form of prostate cancer. Importantly, our recent work examining metastatic biopsy samples demonstrates NEPC is increasing in frequency. In contrast to prostate adenocarcinomas that express a luminal gene expression program, NEPC tumors expre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coleman, Daniel J., Sampson, David A., Sehrawat, Archana, Kumaraswamy, Anbarasu, Sun, Duanchen, Wang, Yuzhuo, Schwartzman, Jacob, Urrutia, Joshua, Lee, Ahn R., Coleman, Ilsa M., Nelson, Peter S., Dong, Xuesen, Morrissey, Colm, Corey, Eva, Xia, Zheng, Yates, Joel A., Alumkal, Joshi J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2020
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218227/ https://www.ncbi.nlm.nih.gov/pubmed/32403054 http://dx.doi.org/10.1016/j.neo.2020.04.002

Ejemplares similares

LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase function
por: Kumaraswamy, Anbarasu, et al.
Publicado: (2023)

Establishment of a neuroendocrine prostate cancer model driven by the RNA splicing factor SRRM4
por: Li, Yinan, et al.
Publicado: (2017)

BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program
por: Kim, Dae-Hwan, et al.
Publicado: (2021)

Roles of Alternative RNA Splicing of the Bif-1 Gene by SRRM4 During the Development of Treatment-induced Neuroendocrine Prostate Cancer
por: Gan, Yu, et al.
Publicado: (2018)

SRRM2 organizes splicing condensates to regulate alternative splicing
por: Xu, Shaohai, et al.
Publicado: (2022)

A novel mechanism of SRRM4 in promoting neuroendocrine prostate cancer development via a pluripotency gene network
por: Lee, Ahn R., et al.
Publicado: (2018)

Cabozantinib can block growth of neuroendocrine prostate cancer patient-derived xenografts by disrupting tumor vasculature
por: Labrecque, Mark P., et al.
Publicado: (2021)

Corrigendum to ‘Roles of alternative RNA splicing of the Bif-1 gene by SRRM4 during the development of treatment-induced neuroendocrine prostate cancer’. [EBioMedicine 31 (2018) 267–275>
por: Gan, Yu, et al.
Publicado: (2020)

The Role of Epigenetic Change in Therapy-Induced Neuroendocrine Prostate Cancer Lineage Plasticity
por: Storck, William K., et al.
Publicado: (2022)

SRRM2, a Potential Blood Biomarker Revealing High Alternative Splicing in Parkinson's Disease
por: Shehadeh, Lina A., et al.
Publicado: (2010)

SRRM4-dependent neuron-specific alternative splicing of protrudin transcripts regulates neurite outgrowth
por: Ohnishi, Takafumi, et al.
Publicado: (2017)

A Mutation in the Srrm4 Gene Causes Alternative Splicing Defects and Deafness in the Bronx Waltzer Mouse
por: Nakano, Yoko, et al.
Publicado: (2012)

Essential roles for the splicing regulator nSR100/SRRM4 during nervous system development
por: Quesnel-Vallières, Mathieu, et al.
Publicado: (2015)

Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate Cancers
por: Zhang, Ailin, et al.
Publicado: (2023)

A germline mutation in SRRM2, a splicing factor gene, is implicated in papillary thyroid carcinoma predisposition
por: Tomsic, Jerneja, et al.
Publicado: (2015)

A convergent malignant phenotype in B-cell acute lymphoblastic leukemia involving the splicing factor SRRM1
por: Closa, Adria, et al.
Publicado: (2022)

SON and SRRM2 are essential for nuclear speckle formation
por: Ilik, İbrahim Avşar, et al.
Publicado: (2020)

Neuronal-specific microexon splicing of TAF1 mRNA is directly regulated by SRRM4/nSR100
por: Capponi, Simona, et al.
Publicado: (2019)

Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression through c-Myc Upregulation
por: Gao, Lina, et al.
Publicado: (2013)

Therapeutic Implications for Intrinsic Phenotype Classification of Metastatic Castration-Resistant Prostate Cancer
por: Coleman, Ilsa M., et al.
Publicado: (2022)

SRRM4 Expands the Repertoire of Circular RNAs by Regulating Microexon Inclusion
por: Conn, Vanessa M., et al.
Publicado: (2020)

Cellular Adhesion Promotes Prostate Cancer Cells Escape from Dormancy
por: Ruppender, Nazanin, et al.
Publicado: (2015)

Molecular Testing Identifies Determinants of Exceptional Response and Guides Precision Therapy in a Patient with Lethal, Treatment-emergent Neuroendocrine Prostate Cancer
por: Turina, Claire B, et al.
Publicado: (2019)

Mismatch repair enzyme expression in primary and castrate resistant prostate cancer
por: Nghiem, Belinda, et al.
Publicado: (2016)

Alternative RNA splicing of the GIT1 gene is associated with neuroendocrine prostate cancer
por: Lee, Ahn R., et al.
Publicado: (2018)

Maintenance of MYC expression promotes de novo resistance to BET bromodomain inhibition in castration-resistant prostate cancer
por: Coleman, Daniel J., et al.
Publicado: (2019)

Silencing of SRRM4 suppresses microexon inclusion and promotes tumor growth across cancers
por: Head, Sarah A., et al.
Publicado: (2021)

Splicing- and demethylase-independent functions of LSD1 in zebrafish primitive hematopoiesis
por: Tamaoki, Junya, et al.
Publicado: (2020)

Cellular androgen content influences enzalutamide agonism of F877L mutant androgen receptor
por: Coleman, Daniel J., et al.
Publicado: (2016)

Development of Neuroendocrine Prostate Cancers by the Ser/Arg Repetitive Matrix 4-Mediated RNA Splicing Network
por: Lee, Ahn R., et al.
Publicado: (2018)

Chemokine receptor CXCR7 activates Aurora Kinase A and promotes neuroendocrine prostate cancer growth
por: Gritsina, Galina, et al.
Publicado: (2023)

Single cell transcriptomic analysis of prostate cancer cells
por: Welty, Christopher J, et al.
Publicado: (2013)

Specialization of the photoreceptor transcriptome by Srrm3-dependent microexons is required for outer segment maintenance and vision
por: Ciampi, Ludovica, et al.
Publicado: (2022)

Familial and genetic association with neurodevelopmental disorders caused by a heterozygous variant in the SRRM2 gene
por: Zhang, Tao, et al.
Publicado: (2023)

Alternative RNA splicing of the MEAF6 gene facilitates neuroendocrine prostate cancer progression
por: Lee, Ahn R., et al.
Publicado: (2017)

Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer
por: Sharp, Adam, et al.
Publicado: (2018)

A gapmer antisense oligonucleotide targeting SRRM4 is a novel therapeutic medicine for lung cancer
por: Shimojo, Masahito, et al.
Publicado: (2019)

Effect of GATAD1 regulating the SRRM2 gene on recurrence of thyroid tumor and its molecular mechanism
por: Wang, Xingquan, et al.
Publicado: (2022)

Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity
por: Westbrook, Thomas C., et al.
Publicado: (2022)

Srrm234, but not canonical SR and hnRNP proteins, drive inclusion of Dscam exon 9 variable exons
por: Ustaoglu, Pinar, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_acgf5k4h9o47b777g6kotgslv3